CG Oncology (CGON) Non-cash Items (2023 - 2026)

CG Oncology has reported Non-cash Items for 4 years, with the latest figure at $382.9 million in Q1 2026.

• For the quarter ending Q1 2026, Non-cash Items rose 338.54% year-over-year to $382.9 million; the trailing twelve-month figure through Mar 2026 stood at $382.9 million (up 338.54% YoY), and the FY2025 full-year result was $198.5 million, up 83.57% from the prior year.
• Non-cash Items for Q1 2026 stood at $382.9 million, up from $198.5 million in the prior quarter.
• The five-year high for Non-cash Items was $382.9 million in Q1 2026, with the low at $40.3 million in Q4 2023.
• Historically, Non-cash Items has averaged $165.6 million across 4 years, with a median of $155.1 million in 2024.
• Annual changes were most pronounced in 2025 — Non-cash Items tumbled 62.23% — and 2026, when it soared 338.54%.
• CG Oncology's Non-cash Items stood at $40.3 million in 2023, then jumped by 168.44% to $108.2 million in 2024, then jumped by 83.57% to $198.5 million in 2025, then jumped by 92.85% to $382.9 million in 2026.
• The last three Non-cash Items figures came in at $382.9 million (Q1 2026), $198.5 million (Q4 2025), and $190.7 million (Q3 2025), per Business Quant data.